Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|October 23, 2021
Risk of Non-Vertebral Fracture in Gout Compared to Rheumatoid ArthritisSoo-Kyung Cho, Jun Liu, Yinzhu Jin, et al.
Arthritis Care & Research|May 14, 2013
Risk of venous thromboembolism in patients with rheumatoid arthritisSeoyoung C Kim, Sebastian Schneeweiss, Jun Liu, et al.
Annals of Internal Medicine|August 2, 2016
Bioequivalence of Biosimilar Tumor Necrosis Factor-α Inhibitors Compared With Their Reference Biologics: A Systematic ReviewFrancine Chingcuanco, Jodi B Segal, Seoyoung C Kim, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 25, 2017
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness researchPhilip A Levin, Hiep Nguyen, Eric T Wittbrodt, et al.
Arthritis Care & Research|August 18, 2012
Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort studySeoyoung C Kim, Craig Newcomb, David Margolis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort StudyRishi J Desai, Ajinkya Pawar, Michael E Weinblatt, et al.
Clinical Pharmacology and Therapeutics|June 2, 2022
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational DataAndrei Barbulescu, Johan Askling, Saedis Saevarsdottir, et al.
Arthritis Care & Research|December 21, 2018
Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort StudySarah K Chen, Katherine P Liao, Jun Liu, et al.
Clinical Pharmacology and Therapeutics|May 24, 2021
Calibrating Real-World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's DiseaseJulien Kirchgesner, Rishi J Desai, Laurent Beaugerie, et al.
Ophthalmology. Retina|July 1, 2022
Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic RetinopathyMiin Roh, Helen Tesfaye, Seoyoung C Kim, et al.
Pageof 19